FDG PET/CT as a Prognostic Biomarker in the Era of Molecular-Targeting Therapies: Max SUVmax Predicts Survival of Patients With Advanced Renal Cell Carcinoma
BMC Cancer - United Kingdom
doi 10.1186/s12885-016-2097-4
Full Text
Open PDFAbstract
Available in full text
Date
February 8, 2016
Authors
Publisher
Springer Science and Business Media LLC